COMMODORE CAPITAL LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
CC COMMODORE CAPITAL LP | Institutional Filer | ▲ 15.06% | $1.73B | 36 |
Current Portfolio Holdings
Showing all 36 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RLAY | Relay Therapeutics, Inc. | Healthcare | 17.0M | $169.2M | 9.79% |
| 2 | ALKS | Alkermes plc | Healthcare | 4.2M | $148.5M | 8.59% |
| 3 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 3.3M | $128.4M | 7.43% |
| 4 | COGT | Cogent Biosciences, Inc. | Healthcare | 2.9M | $111.2M | 6.43% |
| 5 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 1.9M | $96.5M | 5.58% |
| 6 | TYRA | Tyra Biosciences, Inc. | Healthcare | 2.5M | $94.8M | 5.48% |
| 7 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 2.7M | $85.5M | 4.95% |
| 8 | NUVL | Nuvalent, Inc. | Healthcare | 834K | $85.4M | 4.94% |
| 9 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 5.7M | $78.5M | 4.54% |
| 10 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 750K | $62.5M | 3.61% |
| 11 | ANRO | Alto Neuroscience, Inc. | Healthcare | 2.7M | $61.2M | 3.54% |
| 12 | PHVS | Pharvaris N.V. | Healthcare | 1.9M | $54.2M | 3.14% |
| 13 | ERAS | Erasca, Inc. | Healthcare | 3.2M | $51.4M | 2.97% |
| 14 | GLTO | Galecto, Inc. | Healthcare | 1.9M | $50.2M | 2.91% |
| 15 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 825K | $48.0M | 2.78% |
Showing 1 to 15 of 36 holdings